丁力医师:请与我们联系上传伦理审批文件。 多感觉互作镜像疗法疗效及机制研究(上肢)

注册号:

Registration number:

ChiCTR2100041966 

最近更新日期:

Date of Last Refreshed on:

2021-03-29 02:26:08 

注册时间:

Date of Registration:

2021-01-10 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

丁力医师:请与我们联系上传伦理审批文件。 多感觉互作镜像疗法疗效及机制研究(上肢)

Public title:

efficacy and mechanism of multi-sensory interaction based mirror therapy (upper limb)

注册题目简写:

English Acronym:

研究课题的正式科学名称:

多感觉互作镜像疗法对脑卒中后上肢运动功能恢复的网络调制与重塑动力学机制研究

Scientific title:

effect of multi-sensory interaction based mirror therapy on network modulation and neural plasticity of upper limb rehabilitation after stroke

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

丁力 

研究负责人:

丁力 

Applicant:

Ding Li 

Study leader:

Ding Li 

申请注册联系人电话:

Applicant telephone:

+86 13817826242

研究负责人电话:

Study leader's
telephone:

+86 13817826242

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

leodin@163.com

研究负责人电子邮件:

Study leader's E-mail:

leodin@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市静安区乌鲁木齐中路12号复旦大学附属华山医院门诊六楼康复医学科

研究负责人通讯地址:

上海市静安区乌鲁木齐中路12号复旦大学附属华山医院门诊六楼康复医学科

Applicant address:

12 Middle Urumqi Road, Jing'an District, Shanghai, China

Study leader's address:

12 Middle Urumqi Road, Jing'an District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

复旦大学附属华山医院

Applicant's institution:

Huashan Hospital, Fudan University

研究负责人所在单位:

复旦大学附属华山医院

Affiliation of the Leader:

Huashan Hospital, Fudan University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY2020-1205

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

复旦大学附属华山医院伦理审查委员会(HIRB)

Name of the ethic committee:

The Ethical Review Committee of Huashan Hospital Fudan University (HIRB)

伦理委员会批准日期:

Date of approved by ethic committee:

2020-12-15 00:00:00

伦理委员会联系人:

吴翠云

Contact Name of the ethic committee:

Cui-Yun Wu

伦理委员会联系地址:

上海市乌鲁木齐中路12号

Contact Address of the ethic committee:

12 Middle Urumqi Road, Jing'an District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

复旦大学附属华山医院

Primary sponsor:

Huashan Hospital, Fudan University

研究实施负责(组长)单位地址:

上海市静安区乌鲁木齐中路12号

Primary sponsor's address:

12 Middle Urumqi Road, Jing'an District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属华山医院

具体地址:

静安区乌鲁木齐中路12号

Institution
hospital:

Huashan Hosptial Fudan University

Address:

12 Middle Urumqi Road, Jing'an District

经费或物资来源:

上海市科学技术委员会

Source(s) of funding:

Science and Technology Commission of Shanghai Municipality

研究疾病:

脑卒中  

Target disease:

stroke

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

验证多感觉互作镜像疗法对脑卒中后上肢功能恢复的积极作用及对运动执行、准备网络的调制、重塑作用和机制,为上肢功能康复提供新理论和思路。  

Objectives of Study:

To investigate the effect of multi-sensory interaction based mirror therapy on upper limb rehabilitation, modulation and plasticity of motor preparation network and related mechanism after stroke, which aim to provide original theory.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1. 正在接受其他非侵入式脑刺激干预的患者,例如经颅磁刺激(Transcranial Magnetic Stimulation,TMS)、经颅直流电刺激(transcranial Direct-Current Stimulation, tDCS);
2. 依从性不佳者;
3. 合并其他严重内科疾病(如心衰、呼衰、肾功能不全、不可控的高血压、心律失常、严重冠心病、糖尿病合并症控制欠佳者);
4. 合并任何急、慢性感染者(如肺结核、颅内感染等);
5. 合并妊娠;
6. 同期参加其他临床试验者;
7. 初中文化程度以下者。

Exclusion criteria:

1. Patients receiving other non-invasive brain stimulation therapy including TMS, tDCS;
2. can not complete the treatment protocol, poor compliance;
3. a history of epilepsy, cerebral hemorrhage and serious heart, lung, liver, kidney and other important organ function failure and uncontrolled hypertension, arrhythmia, severe coronary heart disease, diabetes complications been fail controlled;
4. concomitant with any acute or chronic infection, like tuberculosis, intracranial infection;
5. pregnancy;
6. involving in other clinical studies;
7. with junior high school education or below.

研究实施时间:

Study execute time:

From 2021-01-18 00:00:00 To 2022-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-01-18 00:00:00 To 2022-06-30 00:00:00

干预措施:

Interventions:

组别:

试验组A

样本量:

28

Group:

Group A

Sample size:

干预措施:

多感觉互作镜像疗法

干预措施代码:

Intervention:

multi-sensory based MT

Intervention code:

组别:

试验组B

样本量:

28

Group:

Group B

Sample size:

干预措施:

常规镜像疗法

干预措施代码:

Intervention:

conventional MT

Intervention code:

组别:

对照组

样本量:

28

Group:

Control group

Sample size:

干预措施:

双手主/助动训练

干预措施代码:

Intervention:

bilateral hand movement training

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦大学附属华山医院 

单位级别:

三级甲等 

Institution
hospital:

Huashan Hospital, Fudan University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

脑电信号

指标类型:

主要指标

Outcome:

electroencephalogram

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Fugl-Meyer运动功能评分量表

指标类型:

主要指标

Outcome:

Fugl-Meyer Assessment (upper extremity)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

九孔柱

指标类型:

次要指标

Outcome:

9HPT

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

盒子障碍测试

指标类型:

次要指标

Outcome:

BBT

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

功能独立性量表

指标类型:

次要指标

Outcome:

FIM

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

躯体自觉意识问卷

指标类型:

次要指标

Outcome:

Embodiment questionnaire

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

电脑产生随机号

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients were randomized using computer-generated random number allocation

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

对受试者设盲

Blinding:

Blind method for evaluators

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

研究结束后6月按需公开原始数据 请说明共享原始数据的方式

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

raw data can be shared within 6 months after the trail complete

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2021-01-10 15:52:47